Skip to main content

and
  1. Article

    Open Access

    Immune cells lacking Y chromosome show dysregulation of autosomal gene expression

    Epidemiological investigations show that mosaic loss of chromosome Y (LOY) in leukocytes is associated with earlier mortality and morbidity from many diseases in men. LOY is the most common acquired mutation a...

    Jan P. Dumanski, Jonatan Halvardson, Hanna Davies in Cellular and Molecular Life Sciences (2021)

  2. No Access

    Article

    The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells

    Several monoclonal antibodies and inhibitors targeting signalling pathways are being used in personalised medicine. Anti-EGFR antibodies seem to be effective, however, therapy resistance often occurs in colon ...

    Tamás Sticz, Anna Molnár, Titanilla Dankó, Zoltán Hujber in Pathology & Oncology Research (2019)

  3. No Access

    Article

    Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia

    In spite of the improved efficacy of therapy, it still fails in 15–20 % of childhood acute lymphoblastic leukemia (ALL) patients. Recently, altered expression of certain miRNAs (miRs) have been described in AL...

    Karolina Nemes, Monika Csóka, Noémi Nagy, Ágnes Márk in Pathology & Oncology Research (2015)

  4. Article

    Open Access

    Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study

    Targeting signaling pathways is an attractive approach in many malignancies. The PI3K/Akt/mTOR pathway is activated in a number of human neoplasms, accompanied by lower overall and/or disease free survival. mT...

    Ágnes Márk, Melinda Hajdu, Zsófia Váradi, Tamás Béla Sticz, Noémi Nagy in BMC Cancer (2013)